Samuel Riccitelli Net Worth

Samuel Riccitelli biography

Samuel D. Riccitelli serves as Independent Director of the Company. Mr. Riccitelli currently serves as Chairman of the Board of Directors of Precipio, Inc. (NASDAQ: PRPO). From 2012 to 2017, Mr. Riccitelli served as President and Chief Executive Officer and a Director of Signal Genetics., a publicly traded molecular diagnostic company that was ultimately sold to Miragen Therapeutics. Mr. Riccitelli was also previously the Executive Vice President and Chief Operating Officer of Genoptix, Inc., a public traded diagnostic company that was sold to Novartis in 2011.

What is the salary of Samuel Riccitelli?

As the Independent Director of OrthoPediatrics corp, the total compensation of Samuel Riccitelli at OrthoPediatrics corp is $77,786. There are 13 executives at OrthoPediatrics corp getting paid more, with Mark Throdahl having the highest compensation of $1,190,150.

How old is Samuel Riccitelli?

Samuel Riccitelli is 61, he's been the Independent Director of OrthoPediatrics corp since 2017. There are 9 older and 10 younger executives at OrthoPediatrics corp. The oldest executive at OrthoPediatrics corp is Stephen Burns, 76, who is the Independent Director.

What's Samuel Riccitelli's mailing address?

Samuel's mailing address filed with the SEC is C/O ORTHOPEDIATRICS CORP., 2850 FRONTIER DRIVE, WARSAW, IN, 46582.

Insiders trading at OrthoPediatrics corp

Over the last 17 years, insiders at OrthoPediatrics corp have traded over $17,595,944 worth of OrthoPediatrics corp stock and bought 44,994 units worth $1,275,983 . The most active insiders traders include David R Pelizzon, John V. Schaefer oraz Mark C Throdahl. On average, OrthoPediatrics corp executives and independent directors trade stock every 24 days with the average trade being worth of $158,746. The most recent stock trade was executed by Daniel J Gerritzen on 21 August 2024, trading 10,000 units of KIDS stock currently worth $293,000.

What does OrthoPediatrics corp do?

orthopediatrics is the worldwide leader in pediatric orthopedics. we are the first company whose total focus is helping children with orthopaedic conditions and injuries by providing the surgeons who care for them with anatomically appropriate implants. every day, we focus purely on advancing the field of pediatric orthopedics through the innovative development of state-of-the-art technologies, commitment to quality products, and industry-leading support and clinical education with our experienced team of experts. our offering is continuing to expand as we strive to develop all of the necessary implants and instruments that a pediatric orthopedic surgeon needs to treat his/her patients, including: long bone deformity correction & trauma, spine, and sports medicine. as we continue to grow, we are looking for talented professionals to join our cause! visit our website to learn more about current openings, or submit a resume to careers@orthopediatrics.com!

OrthoPediatrics corp executives and stock owners

OrthoPediatrics corp executives and other stock owners filed with the SEC include:

• Mark Throdahl,
  Chief Executive Officer, Director
• Fred Hite,
  Chief Financial Officer, Chief Operating Officer, Director
• Gregory Odle,
  Executive Vice President
• David Bailey,
  President
• Daniel Gerritzen,
  Vice President of Legal and Human Resources, General Counsel, Secretary
• Mark C. Throdahl,
  Exec. Chairman
• Fred L. Hite,
  CFO, Principal Financial & Accounting Officer, COO and Director
• David R. Bailey,
  Pres, CEO & Director
• Gregory A. Odle,
  Exec. VP of Commercialization
• Daniel J. Gerritzen,
  Gen. Counsel & Sec.
• Terry Schlotterback,
  Independent Chairman of the Board
• Marie Infante,
  Independent Director
• Bryan Hughes,
  Independent Director
• Kevin Unger,
  Independent Director
• Samuel Riccitelli,
  Independent Director
• Stephen Burns,
  Independent Director
• Bernie Berry,
  Independent Director
• Harald Ruf,
  Director
• David Pelizzon,
  Director
• Tram Bui,
  IR Contact Officer
• Paul J. Mraz,
  Sr. VP & GM of Scoliosis
• Mark Karshner,
  Sr. VP of International Sales
• Joe Hauser,
  Sr. VP & GM of Trauma & Deformity Correction
• Dr. Peter F. Armstrong M.D.,
  Chief Medical Officer & Chair of Surgeon Advisory Board
• Joel Batts,
  Sr. VP of Science & Technology
• Jennifer N. Pritzker,
  10% owner
• Frederick Hurley,
  Senior VP Merchandising
• Craig Kimbrough Currie,
  Senior VP My Twinn & BabyUnive
• Barry Hollingsworth,
  Chief Financial Officer
• John V. Schaefer,
  Director
• Edward John Ulbrich,
  Director
• Michael J. Wagner,
  Chief Executive Officer
• Christopher Cummings,
  Senior VP & CIO
• Pamela Nadine Abrams,
  Director
• Joseph Frank Rosales,
  Director
• Direct Capital, L.L.C.D. E....,
  
• John C Textor,
  Director
• E. Shaw Laminar Acquisition...,
  
• Harold Ruf,
  Director
• George Sinclair Mitchell Dyer,
  Director
• Joseph W Hauser,
  Pres. Trauma & Def. Correction
• Capital Llc Squadron Capita...,
  
• Jimmy Duane Mc Donald,
  Director